{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study&page=30", "query": { "intervention": "Study", "page": 30 }, "page_size": 10 }, "pagination": { "page": 30, "page_size": 10, "total_count": 107227, "total_pages": 10723, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study&page=31&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study&page=29&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T04:11:27.535Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00560716", "title": "A Phase I Pharmacologic Study of CYC116, an Oral Aurora Kinase Inhibitor, in Patients With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors" ], "interventions": [ { "name": "CYC116", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cyclacel Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2007-06", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2021-12-22", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 2, "location_summary": "Buffalo, New York • San Antonio, Texas", "locations": [ { "city": "Buffalo", "state": "New York" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00560716" }, { "nct_id": "NCT01721616", "title": "Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Endometritis" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" }, { "name": "Cefazolin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Missouri, Kansas City", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 0, "start_date": "2012-11", "completion_date": "2014-11", "has_results": false, "last_update_posted_date": "2015-05-05", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01721616" }, { "nct_id": "NCT00217516", "title": "Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "selenium", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Roswell Park Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "MALE", "summary": "Male only" }, "enrollment_count": 18, "start_date": "2005-03", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2012-02-09", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00217516" }, { "nct_id": "NCT04459416", "title": "Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Myeloma", "Hodgkin Disease", "Non-Hodgkin Lymphoma" ], "interventions": [ { "name": "Acupuncture", "type": "OTHER" }, { "name": "opioid", "type": "DRUG" }, { "name": "Assessments", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 299, "start_date": "2020-06-30", "completion_date": "2027-06", "has_results": true, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 2, "location_summary": "New York, New York • Seattle, Washington", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04459416" }, { "nct_id": "NCT02538016", "title": "TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystinuria" ], "interventions": [ { "name": "Tolvaptan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Caleb Nelson", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "12 Years to 29 Years" }, "enrollment_count": 4, "start_date": "2016-10", "completion_date": "2018-12", "has_results": true, "last_update_posted_date": "2020-07-10", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02538016" }, { "nct_id": "NCT06547216", "title": "Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "FSHD", "FSHD1", "FSHD2", "FMD", "FMD2", "Fascioscapulohumeral Muscular Dystrophy", "Fascioscapulohumeral Muscular Dystrophy Type 1", "Fascioscapulohumeral Muscular Dystrophy Type 2", "Dystrophies, Facioscapulohumeral Muscular", "Dystrophy, Facioscapulohumeral Muscular", "Facioscapulohumeral Muscular Dystrophy 1", "Facioscapulohumeral Muscular Dystrophy 2", "Facio-Scapulo-Humeral Dystrophy", "Atrophy, Facioscapulohumeral", "Atrophies, Facioscapulohumeral", "Facioscapulohumeral Atrophy", "Muscular Dystrophies", "Muscular Dystrophy, Facioscapulohumeral", "FSH Muscular Dystrophy", "Landouzy Dejerine Dystrophy", "Landouzy-Dejerine Muscular Dystrophy", "Dystrophies, Landouzy-Dejerine", "Dystrophy, Landouzy-Dejerine", "Landouzy-Dejerine Syndrome", "Muscular Dystrophy, Landouzy Dejerine", "Progressive Muscular Dystrophy", "FSH" ], "interventions": [ { "name": "AOC 1020", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avidity Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "72 Years", "sex": "ALL", "summary": "16 Years to 72 Years" }, "enrollment_count": 84, "start_date": "2024-07-25", "completion_date": "2030-06", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 14, "location_summary": "Los Angeles, California • Palo Alto, California • San Diego, California + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06547216" }, { "nct_id": "NCT04412616", "title": "ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced EGFR Positive Solid Tumor" ], "interventions": [ { "name": "ZZ06", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Changchun Intellicrown Pharmaceutical Co. LTD", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2020-09-01", "completion_date": "2026-07-06", "has_results": false, "last_update_posted_date": "2025-06-10", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 3, "location_summary": "Los Angeles, California • Fairway, Kansas • The Bronx, New York", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Fairway", "state": "Kansas" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04412616" }, { "nct_id": "NCT00043784", "title": "SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Unstable Angina", "Myocardial Infarction", "Myocardial Ischemia" ], "interventions": [ { "name": "enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8000, "start_date": "2001-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2008-09-16", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00043784" }, { "nct_id": "NCT04146584", "title": "Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Skin Laxity", "Wrinkle", "Brow Lifting" ], "interventions": [ { "name": "Sofwave Treatments", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Sofwave Medical LTD", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "35 Years to 80 Years" }, "enrollment_count": 93, "start_date": "2019-11-20", "completion_date": "2021-03-30", "has_results": false, "last_update_posted_date": "2021-07-22", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 5, "location_summary": "Sacramento, California • New York, New York • Charlotte, North Carolina + 1 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04146584" }, { "nct_id": "NCT02262533", "title": "Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "N/A - Healthy Subjects" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Atenolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 15, "start_date": "2007-06", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2015-08-10", "last_synced_at": "2026-10-29T04:11:27.535Z", "location_count": 1, "location_summary": "Hamilton, New Jersey", "locations": [ { "city": "Hamilton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02262533" } ] }